OTO Fertility Launches World’s First Diagnostic Wearable and Platform for Predictive Fertility Insight at CES 2026
Las Vegas, NV. (January 6, 2026) — OTO Fertility, a digital health platform developed by OTO Coach, is redefining reproductive...
About OTO Fertility
Built on 40+ Years of Science
Our story began in space medicine in 1984, when our technology helped astronauts make life-and-death decisions in orbit. It later evolved into Omegawave, the performance tool trusted by elite athletes across the NBA, NHL, PGA, and Olympic programs.
Today, OTO Fertility brings that same precision and innovation to reproductive health, transforming the way clinics and patients understand the body’s most complex systems.
From Space to Fertility Care
OTO Fertility began with a bold idea: that understanding the body’s real-time stress response could transform human health.
1984
Our Space-Medicine Origins
Developed to give astronauts real-time insight into their physiological state during critical missions, our core technology began as a life-support innovation in space medicine.
1999
From Orbit to Arena
The technology evolved into Omegawave, empowering coaches and elite athletes to monitor performance readiness and recovery, quickly, accurately, and non-invasively.
2012
Scaling Global Impact
With headquarters established in Finland, Omegawave was recognized as one of the country’s most promising startups and adopted by major sports organizations including the NBA, NHL, NFL, PGA, and IOC.
2022
A New Era with OTO
OTO acquired Omegawave, extending its proven science into new areas of health, beginning with reproductive wellness and fertility care.
Today
Predictive Power
Today, OTO brings that same precision and innovation to reproductive health with OTO Fertility, turning stress-biology insights into clear, predictive guidance to help families navigate their Path to Parenthood™.
Our Scientific Advisors
Behind OTO Fertility stands a distinguished board of scientists, physicians, and innovators whose expertise guides every aspect of our work. Their leadership ensures that each recommendation we make is grounded in proven science, clinical integrity, and a shared commitment to improving reproductive outcomes.
United States
Dr. Alice Domar
PhD
Chief Compassion Officer,
Inception Fertility
Harvard University
Associate Professor
Belgium
Dr. Cristophe Blockeel
MD, PHD REI
Medical Director,
UZ Brussels Fertility Department
Canada
Dr. Mark Tarnopolsky
MD, PHD
CEO/CSO,
Exerkine
McMaster University
Division Head of Neurometabolic Disorders
Dr. Olga Kara
MSc, PhD, MBA
CEO,
O-Brain Research and Consulting
Tampere University
Associate Professor
Canada
Dr. Tish Doyle-Baker
PH, PhD, CSEP-CEP
Member of O’Brien Institute for Public Health, Alberta
Children’s Hospital Research Institute for Child and Maternal Health
Member
Cumming School of Medicine
Member
United States
Hillary Wright
MEd, RDN, LDN
Director of Nutrition,
Boston IVF
Nutrition Educator | Author | Consultant
Our Mission
To set a new standard in reproductive care, one where every person on a fertility journey is supported by clinically validated intelligence, compassionate guidance, and inclusive, science-backed care.
Our Values
Science with Heart
We’re rooted in more than 40 years of validated science but we deliver it with empathy and respect for every fertility journey.
Clarity Over Complexity
We make the complex simple. Our predictive insights transform advanced data into clear, actionable understanding for both patients and providers.
Partnership First
We believe breakthroughs happen through collaboration with clinicians, clinics, and individuals working together toward shared success.
Empowerment Through Intelligence
We don’t just collect data; we make it meaningful. OTO Fertility empowers people to make informed choices that turn insight into action and possibility into progress.
Awards & Credentials
OTO Fertility is recognized by leading research institutions for its innovation in stress biology and reproductive health.
Insights & Research
We share research, insights, and resources to help you make confident, informed decisions on your fertility journey. Explore our latest science-backed articles and guides below.
OTO Fertility’s Scalable Impact Through Science
1,667
Women Helped
1,437
Pregnancies with OTO Fertility
517
Current Standard of Care Pregnancies
920
OTO Fertility number of babies increase
$12.3M
Government Savings
$62.1M
Patient Savings
$74.4M
Total Savings
8,333
Women Helped
7,183
Pregnancies with OTO Fertility
2,583
Current Standard of Care Pregnancies
4,600
OTO Fertility number of babies increase
$61.7M
Government Savings
$310.3M
Patient Savings
$372M
Total Savings
83,333
Women Helped
71,832
Pregnancies with OTO Fertility
25,833
Current Standard of Care Pregnancies
45,999
OTO Fertility number of babies increase
$616.7M
Government Savings
$3.10B
Patient Savings
$3.72B
Total Savings
Benchmarked against Queens Research
77%
Pregnancy rate for women who achieve OTO Fertility Zone
Benchmarked against BORN Ontario 2024 CARTR Report
31%
Current Standard of Care Pregnancies – IVF success rate used
Government savings calculations assume the government pays for one IVF cycle per couple and OTO Fertility per investment level. This would be system level savings due to reduced IVF demand.
Reduced Wait Times
2.0 Yrs to ~1.2 Yrs
(~10 months faster)
ROI
~$74M
total system savings per $1M invested (~74x return)
Research suggests couples using OTO Fertility reach pregnancy nearly 2.5 years sooner than those relying on current standard of care. This shorter journey translates directly into less emotional stress, lower treatment costs, and significant public health efficiency gains (e.g., faster system turnover and reduced wait times.)